TCR crosslinking promotes Crk adaptor protein binding to tyrosine-phosphorylated CD3ζ chain. 2017

Guangyu Dong, and Rachel Kalifa, and Pulak Ranjan Nath, and Sigal Gelkop, and Noah Isakov
The Shraga Segal Department of Microbiology, Immunology and Genetics, Faculty of Health Sciences and the Cancer Research Center, Ben Gurion University of the Negev, P.O.B. 653, Beer Sheva 84105, Israel. Electronic address: gdong@upenn.edu.

T cell antigen receptor (TCR) binding of a peptide antigen presented by antigen-presenting cells (APCs) in the context of surface MHC molecules initiates signaling events that regulate T cell activation, proliferation and differentiation. A key event in the activation process is the phosphorylation of the conserved tyrosine residues within the CD3 chain immunoreceptor tyrosine-based activation motifs (ITAMs), which operate as docking sites for SH2 domain-containing effector proteins. Phosphorylation of the CD3ζ ITAMs renders the CD3 chain capable of binding the ζ-chain associated protein 70 kDa (ZAP70), a protein tyrosine kinase that is essential for T cell activation. We found that TCR/CD3 crosslinking in Jurkat T cells promotes the association of Crk adaptor proteins with the transiently phosphorylated CD3ζ chain. Pull down assays using bead-immobilized GST fusion proteins revealed that the Crk-SH2 domain mediates binding of phospho-CD3ζ. Phospho-CD3ζ binding is selective and is mediated by the three types of Crk, including CrkI, CrkII, and CrkL, but not by other SH2 domain-containing adaptor proteins, such as Grb2, GRAP and Nck. Crk interaction with phospho-CD3ζ is rapid and transient, peaking 1 min post TCR/CD3 crosslinking. The results suggest the involvement of Crk adaptor proteins in the early stages of T cell activation in which Crk might help recruiting effector proteins to the vicinity of the phospho-CD3ζ and contribute to the fine-tuning of the TCR/CD3-coupled signal transduction pathways.

UI MeSH Term Description Entries
D011485 Protein Binding The process in which substances, either endogenous or exogenous, bind to proteins, peptides, enzymes, protein precursors, or allied compounds. Specific protein-binding measures are often used as assays in diagnostic assessments. Plasma Protein Binding Capacity,Binding, Protein
D011948 Receptors, Antigen, T-Cell Molecules on the surface of T-lymphocytes that recognize and combine with antigens. The receptors are non-covalently associated with a complex of several polypeptides collectively called CD3 antigens (CD3 COMPLEX). Recognition of foreign antigen and the major histocompatibility complex is accomplished by a single heterodimeric antigen-receptor structure, composed of either alpha-beta (RECEPTORS, ANTIGEN, T-CELL, ALPHA-BETA) or gamma-delta (RECEPTORS, ANTIGEN, T-CELL, GAMMA-DELTA) chains. Antigen Receptors, T-Cell,T-Cell Receptors,Receptors, T-Cell Antigen,T-Cell Antigen Receptor,T-Cell Receptor,Antigen Receptor, T-Cell,Antigen Receptors, T Cell,Receptor, T-Cell,Receptor, T-Cell Antigen,Receptors, T Cell Antigen,Receptors, T-Cell,T Cell Antigen Receptor,T Cell Receptor,T Cell Receptors,T-Cell Antigen Receptors
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D001665 Binding Sites The parts of a macromolecule that directly participate in its specific combination with another molecule. Combining Site,Binding Site,Combining Sites,Site, Binding,Site, Combining,Sites, Binding,Sites, Combining
D014407 Tumor Cells, Cultured Cells grown in vitro from neoplastic tissue. If they can be established as a TUMOR CELL LINE, they can be propagated in cell culture indefinitely. Cultured Tumor Cells,Neoplastic Cells, Cultured,Cultured Neoplastic Cells,Cell, Cultured Neoplastic,Cell, Cultured Tumor,Cells, Cultured Neoplastic,Cells, Cultured Tumor,Cultured Neoplastic Cell,Cultured Tumor Cell,Neoplastic Cell, Cultured,Tumor Cell, Cultured
D050737 Proto-Oncogene Proteins c-crk Signal transducing adaptor proteins that contain SRC HOMOLOGY DOMAINS and play a role in CYTOSKELETON reorganization. c-crk protein is closely related to ONCOGENE PROTEIN V-CRK and includes several alternatively spliced isoforms. c-crk Protein,crk Proto-Oncogene Proteins,CRKI Protein,CRKII Protein,CT10 Regulator of Kinase Protein,Crk-1 Protein,Crk-2 Protein,Crk3 Protein,CrkII Adapter Protein,CrkIII Protein,Proto-Oncogene Protein c-crk,Proto-Oncogene Protein c-crk-1,Proto-Oncogene Protein c-crk-2,Proto-Oncogene Protein c-crk-3,c-CrkII Protein,c-CrkIII Protein,c-crk Proto-Oncogene Proteins,c-crk-2 Proto-Oncogene Protein,c-crk-3 Proto-Oncogene Protein,c-crk-I Proto-Oncogene Protein,c-crkI Protein,Adapter Protein, CrkII,Crk 1 Protein,Crk 2 Protein,Proteins c-crk, Proto-Oncogene,Proto Oncogene Protein c crk,Proto Oncogene Protein c crk 1,Proto Oncogene Protein c crk 2,Proto Oncogene Protein c crk 3,Proto Oncogene Proteins c crk,Proto-Oncogene Protein, c-crk-2,Proto-Oncogene Protein, c-crk-3,Proto-Oncogene Protein, c-crk-I,Proto-Oncogene Proteins, c-crk,Proto-Oncogene Proteins, crk,c CrkII Protein,c CrkIII Protein,c crk 2 Proto Oncogene Protein,c crk 3 Proto Oncogene Protein,c crk I Proto Oncogene Protein,c crk Proto Oncogene Proteins,c-crk, Proto-Oncogene Protein,c-crk, Proto-Oncogene Proteins,c-crk-1, Proto-Oncogene Protein,c-crk-2, Proto-Oncogene Protein,c-crk-3, Proto-Oncogene Protein,crk Proto Oncogene Proteins
D051746 ZAP-70 Protein-Tyrosine Kinase A protein tyrosine kinase that is required for T-CELL development and T-CELL ANTIGEN RECEPTOR function. 70 kDa Zeta-Associated Protein,Syk-Related Tyrosine Kinase,ZAP-70 Kinase,ZAP-70 Protein,zeta-Chain Associated Protein Kinase (ZAP-70),70 kDa Zeta Associated Protein,Kinase, ZAP-70,Protein-Tyrosine Kinase, ZAP-70,Syk Related Tyrosine Kinase,Tyrosine Kinase, Syk-Related,ZAP 70 Kinase,ZAP 70 Protein,ZAP 70 Protein Tyrosine Kinase
D019000 Phosphotyrosine An amino acid that occurs in endogenous proteins. Tyrosine phosphorylation and dephosphorylation plays a role in cellular signal transduction and possibly in cell growth control and carcinogenesis. Tyrosine-O-phosphate,Tyrosine O phosphate

Related Publications

Guangyu Dong, and Rachel Kalifa, and Pulak Ranjan Nath, and Sigal Gelkop, and Noah Isakov
July 1996, Journal of immunology (Baltimore, Md. : 1950),
Guangyu Dong, and Rachel Kalifa, and Pulak Ranjan Nath, and Sigal Gelkop, and Noah Isakov
December 1993, Molecular and cellular biology,
Guangyu Dong, and Rachel Kalifa, and Pulak Ranjan Nath, and Sigal Gelkop, and Noah Isakov
January 2012, PloS one,
Guangyu Dong, and Rachel Kalifa, and Pulak Ranjan Nath, and Sigal Gelkop, and Noah Isakov
May 2009, Seikagaku. The Journal of Japanese Biochemical Society,
Guangyu Dong, and Rachel Kalifa, and Pulak Ranjan Nath, and Sigal Gelkop, and Noah Isakov
January 2014, Immunology and cell biology,
Guangyu Dong, and Rachel Kalifa, and Pulak Ranjan Nath, and Sigal Gelkop, and Noah Isakov
May 2004, Biochemical and biophysical research communications,
Guangyu Dong, and Rachel Kalifa, and Pulak Ranjan Nath, and Sigal Gelkop, and Noah Isakov
October 2008, Immunity,
Guangyu Dong, and Rachel Kalifa, and Pulak Ranjan Nath, and Sigal Gelkop, and Noah Isakov
February 1995, The Journal of biological chemistry,
Guangyu Dong, and Rachel Kalifa, and Pulak Ranjan Nath, and Sigal Gelkop, and Noah Isakov
July 1996, Oncogene,
Copied contents to your clipboard!